Literature DB >> 15192780

Surgical outcome of combined pulmonary and atrial resection for lung cancer.

A Bobbio1, P Carbognani, M Grapeggia, M Rusca, F Sartori, P Bobbio, F Rea.   

Abstract

OBJECTIVES: The study was carried out to assess the short and long-term outcome of patients with non-small cell lung cancer infiltrating the left atrium treated by surgery.
METHODS: We retrospectively collected the hospital files of twenty-three consecutive patients operated on between 1982 and 2001 in two units of Thoracic Surgery. Four patients received an induction regimen. Fourteen right pneumonectomies, 8 left pneumonectomies and 1 right inferior lobectomy were performed. No cardiopulmonary bypass was employed.
RESULTS: In all patients the diagnosis of T4 atrial invasion was confirmed by pathological examination. A complete resection was achieved in nineteen patients (83%). With respect to nodal staging, there were 13 N0, 5 N1 and 4 N2 cases, respectively. Two deaths occurred during the one month postoperative period (9%). Three patients had postoperative atrial fibrillation. Two other patients had postpneumonectomy empyema without bronchopleural fistula and recovered, one after thoracoscopic debridement and the second after open window thoracostomy. Follow-up was completed on September 2002; only one patient was lost to follow-up. Median survival, excluding the perioperative mortality, was 20 months (range 4 - 62 months). The survival rate, calculated with the Kaplan-Meier method, was estimated as 63% at 1 year, 2 % at 3 years and 10% at 5 years. Using a Cox model analysis, lymph node stage and completeness of resection were not independent prognostic factors.
CONCLUSIONS: In cases of NSCLC with left atrial invasion complete resection is technically feasible in most instances without cardiopulmonary bypass. The acceptable operative risk and the encouraging long-term survival observed in this series suggest that NSCLC invading the left atrium should not be systematically considered as a definitive contraindication to surgery.

Entities:  

Mesh:

Year:  2004        PMID: 15192780     DOI: 10.1055/s-2004-817813

Source DB:  PubMed          Journal:  Thorac Cardiovasc Surg        ISSN: 0171-6425            Impact factor:   1.827


  5 in total

1.  Atrial resection for lung cancer: morbidity, mortality, and long-term follow-up.

Authors:  Andreas Kuehnl; Michael Lindner; Hans-Martin Hornung; Hauke Winter; Karl-Walter Jauch; Rudolf A Hatz; Christian Graeb
Journal:  World J Surg       Date:  2010-09       Impact factor: 3.352

Review 2.  Extended surgery for T4 lung cancer: a 30 years' experience.

Authors:  P G Dartevelle; D Mitilian; E Fadel
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-03-27

3.  Initial extended resection or neoadjuvant therapy for T4 non-small cell lung cancer-What is the evidence?

Authors:  Ilkka Ilonen; David R Jones
Journal:  Shanghai Chest       Date:  2018-10-11

Review 4.  Atrial resection for T4 non-small cell lung cancer with left atrium involvement: a systematic review and meta-analysis of survival.

Authors:  Shadi Hamouri; Nasr Alrabadi; Sebawe Syaj; Hassan Abushukair; Obada Ababneh; Leen Al-Kraimeen; Majd Al-Sous; Erich Hecker
Journal:  Surg Today       Date:  2022-01-09       Impact factor: 2.549

5.  Surgical outcome of patients with lung cancer involving the left atrium.

Authors:  Takuma Tsukioka; Makoto Takahama; Ryu Nakajima; Michitaka Kimura; Hidetoshi Inoue; Ryoji Yamamoto
Journal:  Int J Clin Oncol       Date:  2016-06-04       Impact factor: 3.402

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.